Quote:

---

I'm in a trading chatroom that usually has approximately 500 active traders on any given day. CYDY is looked at as an OTC pump in that chatroom, and Redchip is looked at as a notorious OTC pump promoter.

---

Traders are not known for their in depth research. So they'll miss out on the best stock I've ever ran across.

When I first started researching leronlimab's use in just HIV, even with the financials I couldn't figure out why this was sitting at 50 cents. I kept looking for the item that I must be missing that would make it a bad investment. Nothing showed up so I took a small position. After I started reading medical papers on the other indications it became my only position. The only time in my lifetime I did not diversify.